Van Gerven et al., 2018
In a landmark 1992 study, obese adults with a history of failing to lose weight underreported their intake by an average of 47% 3
Each advancement aims to improve: weight loss outcomes insulin sensitivity appetite regulation metabolic flexibility Retatrutide is particularly gaining attention because of its triple-hormone mechanism targeting: GLP-1 GIP glucagon receptors This may potentially lead to greater metabolic effects and enhanced fat reduction
Personalizing the Approach: Protocols That Work Functional providers can create tailored plans using: Supplement protocols to support appetite, energy, and blood sugar High-protein, nutrient-dense meals to prevent lean mass loss Time-restricted eating for glycemic control and satiety Movement prescriptions for muscle preservation and mitochondrial health Gut support for motility and microbiome balance These strategies help patients experience sustainable resultswhether theyre on GLP-1 meds, tapering off, or looking for a more natural path from the start
However, extending the results of MC1R interaction with both - and -opioid systems raises the possibility that in dark-haired humans there is an endogenous pain inhibition system resulting from MC1R activation
Great service, quick turn around
